AVIRON
10-Q, EX-27.1, 2000-08-11
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: AVIRON, 10-Q, EX-10.30, 2000-08-11
Next: BEACH FIRST NATIONAL BANCSHARES INC, 10QSB, 2000-08-11



<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000

<S>                             <C>
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-START>                             JAN-01-2000
<PERIOD-END>                               JUN-30-2000
<CASH>                                          76,135
<SECURITIES>                                    37,432
<RECEIVABLES>                                    3,768
<ALLOWANCES>                                         0
<INVENTORY>                                      2,082
<CURRENT-ASSETS>                               120,596
<PP&E>                                          37,298
<DEPRECIATION>                                  12,498
<TOTAL-ASSETS>                                 152,158
<CURRENT-LIABILITIES>                           14,054
<BONDS>                                        114,075
                                0
                                          0
<COMMON>                                            21
<OTHER-SE>                                      25,004
<TOTAL-LIABILITY-AND-EQUITY>                   152,158
<SALES>                                              0
<TOTAL-REVENUES>                                 5,035
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                                51,911
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               4,145
<INCOME-PRETAX>                               (48,651)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                           (48,651)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (48,651)
<EPS-BASIC>                                     (2.55)
<EPS-DILUTED>                                   (2.55)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission